Aicore begins collaboration with Medis

On December 6, 2012, Aicore began working on developing its product portfolio with one of the largest global generic pharmaceutical companies — Medis, which is part of the Actavis Group (USA).

This partnership allows Aicore to supply emerging markets within the CIS and Eastern Europe with products that align with the company’s philosophy — focusing on evidence-based medications capable of improving people’s quality of life.

The choice of product categories is determined by their significance for the health of our potential consumers.

The manufacturing sites to be used for Aicore’s needs are located exclusively in European countries. This ensures that all stages of the production process meet the highest industry standards.